139 related articles for article (PubMed ID: 30032686)
1. Healthcare utilization and costs with fixed-source versus variable-source tacrolimus in patients receiving a kidney transplant.
Bunniran S; Lee E; Kamble P; Suehs B; Franks B; Schwartz J; Thal G; Spalding J
J Med Econ; 2018 Nov; 21(11):1067-1074. PubMed ID: 30032686
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of clinical and safety outcomes associated with conversion from brand-name to generic tacrolimus in transplant recipients enrolled in an integrated health care system.
Spence MM; Nguyen LM; Hui RL; Chan J
Pharmacotherapy; 2012 Nov; 32(11):981-7. PubMed ID: 23074134
[TBL] [Abstract][Full Text] [Related]
3. Healthcare resource utilization and direct medical costs associated with index and recurrent
Feuerstadt P; Stong L; Dahdal DN; Sacks N; Lang K; Nelson WW
J Med Econ; 2020 Jun; 23(6):603-609. PubMed ID: 31999199
[No Abstract] [Full Text] [Related]
4. Assessment of the frequency and costs of posttransplantation hospitalizations in patients receiving tacrolimus versus cyclosporine.
Neylan JF; Sullivan EM; Steinwald B; Goss TF
Am J Kidney Dis; 1998 Nov; 32(5):770-7. PubMed ID: 9820446
[TBL] [Abstract][Full Text] [Related]
5. A UK analysis of the cost of switching renal transplant patients from an immediate-release to a prolonged-release formulation of tacrolimus based on differences in trough concentration variability.
Muduma G; Odeyemi I; Pollock RF
J Med Econ; 2014 Jul; 17(7):520-6. PubMed ID: 24754700
[TBL] [Abstract][Full Text] [Related]
6. Generics: are all immunosuppression agents created equally?
Hauch A; John M; Smith A; Dortonne I; Patel U; Kandil E; Killackey M; Paramesh A; Lee B; Zhang R; Buell JF
Surgery; 2015 Oct; 158(4):1049-54; discussion 1054-5. PubMed ID: 26206317
[TBL] [Abstract][Full Text] [Related]
7. Tacrolimus versus cyclosporin in renal transplantation in Italy: cost-minimisation and cost-effectiveness analyses.
Lazzaro C; McKechnie T; McKenna M
J Nephrol; 2002; 15(5):580-8. PubMed ID: 12455727
[TBL] [Abstract][Full Text] [Related]
8. The cost effectiveness of tacrolimus versus microemulsified cyclosporin: a 10-year model of renal transplantation outcomes.
Orme ME; Jurewicz WA; Kumar N; McKechnie TL
Pharmacoeconomics; 2003; 21(17):1263-76. PubMed ID: 14986738
[TBL] [Abstract][Full Text] [Related]
9. Clinical burden and healthcare resource utilization among patients with chronic hypoparathyroidism, overall and by adequately vs not adequately controlled disease: a multi-country chart review.
Chen K; Krasner A; Li N; Xiang CQ; Totev T; Xie J
J Med Econ; 2019 Nov; 22(11):1141-1152. PubMed ID: 31124721
[No Abstract] [Full Text] [Related]
10. The Association of Tacrolimus Formulation Switching with Trough Concentration Variability: A Retrospective Cohort Study of Tacrolimus Use Post-Kidney Transplantation Based on National Drug Code (NDC) Numbers.
Schwartz JJ; Lee E; Butler AP; Facklam DP; Franks B; Spalding JR; Vassilakis ME; Thal GD; Irish WD
Adv Ther; 2019 Jun; 36(6):1358-1369. PubMed ID: 31004326
[TBL] [Abstract][Full Text] [Related]
11. Economic burden of skeletal-related events in patients with multiple myeloma: analysis of US commercial claims database.
Bhowmik D; Hines DM; Intorcia M; Wade RL
J Med Econ; 2018 Jun; 21(6):622-628. PubMed ID: 29571273
[TBL] [Abstract][Full Text] [Related]
12. Changes in healthcare resource use and costs associated with early versus delayed initiation of atypical antipsychotic adjunctive treatment in major depressive disorder.
Seetasith A; Greene M; Hartry A; Burudpakdee C
J Med Econ; 2018 Sep; 21(9):888-901. PubMed ID: 29862860
[TBL] [Abstract][Full Text] [Related]
13. The impact of persistence with mirabegron usage vs switching to onabotulinumtoxinA on healthcare costs and resource utilization in patients with overactive bladder in the United States.
Ng DB; Espinosa R; Johnson SJ; Walker D; Gooch K
J Med Econ; 2017 Dec; 20(12):1272-1280. PubMed ID: 28805473
[TBL] [Abstract][Full Text] [Related]
14. Retrospective database analysis of healthcare resource utilization and costs in patients who develop post-transplant lymphoproliferative disease within the first year following allogeneic hematopoietic stem cell transplants.
Watson C; Xu H; Princic N; Sruti I; Barlev A
J Med Econ; 2020 Oct; 23(10):1159-1167. PubMed ID: 32643493
[TBL] [Abstract][Full Text] [Related]
15. Healthcare resource utilization and costs in working-age patients with high-risk atherosclerotic cardiovascular disease: findings from a multi-employer claims database.
Zhao Z; Zhu Y; Fang Y; Ye W; McCollam P
J Med Econ; 2015; 18(9):655-65. PubMed ID: 25891183
[TBL] [Abstract][Full Text] [Related]
16. Co-administration of ketoconazole and tacrolimus to kidney transplant recipients: cost minimization and potential metabolic benefits.
Elamin S; El-Magzoub AR; Dablouk N; Mahmoud F; Abbas M
Saudi J Kidney Dis Transpl; 2014 Jul; 25(4):814-8. PubMed ID: 24969193
[TBL] [Abstract][Full Text] [Related]
17. Evaluating the economic implications of non-adherence and antibody-mediated rejection in renal transplant recipients: the role of once-daily tacrolimus in the UK.
Muduma G; Odeyemi I; Pollock RF
J Med Econ; 2015; 18(12):1050-9. PubMed ID: 26201252
[TBL] [Abstract][Full Text] [Related]
18. Economic impact of switching from metoprolol to nebivolol for hypertension treatment: a retrospective database analysis.
Chen S; Tourkodimitris S; Lukic T
J Med Econ; 2014 Oct; 17(10):685-90. PubMed ID: 25007315
[TBL] [Abstract][Full Text] [Related]
19. Healthcare resource use and direct costs in severe aplastic anemia (SAA) patients before and after treatment with eltrombopag.
Cai B; Said Q; Li X; Li FY; Arcona S
J Med Econ; 2020 Mar; 23(3):243-251. PubMed ID: 31686551
[No Abstract] [Full Text] [Related]
20. Immunosuppressive therapy for kidney transplantation in children and adolescents: systematic review and economic evaluation.
Haasova M; Snowsill T; Jones-Hughes T; Crathorne L; Cooper C; Varley-Campbell J; Mujica-Mota R; Coelho H; Huxley N; Lowe J; Dudley J; Marks S; Hyde C; Bond M; Anderson R
Health Technol Assess; 2016 Aug; 20(61):1-324. PubMed ID: 27557331
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
